Clinical Trial Update: Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating veliparib, paclitaxel, and carboplatin in patients with various metastatic or unresectable solid tumors and liver or kidney dysfunction…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Carcinoma of Unknown Primary
• Endometrial Cancer
• Esophageal Cancer
• Head and Neck Cancer
• Lung Cancer
• Ovarian Cancer
• Urothelial Carcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Veliparib (veliparib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Carcinoma, Carcinoma of Unknown Primary | Phase 1 | Status: ACTIVE_NOT_RECRUITING